Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Indian researchers describe new anticancer agent

Jan. 14, 1998

Korean researchers discover new PLC and PI turnover inhibitor from fungal strain

Jan. 14, 1998

U.S. marketing application submitted for AD-32

Jan. 14, 1998

Photofrin enters phase III testing for new indication

Jan. 14, 1998

New anticancer combination associated with high efficacy in phase II metastatic breast cancer trial

Jan. 13, 1998

Analog II: a novel antiestrogen with selective activity against breast cancer

Jan. 13, 1998

Temodal submitted for approval in E.U.

Jan. 13, 1998

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Jan. 13, 1998

Chemogene therapy: a new therapeutic approach on the horizon?

Jan. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...